Clinical trial
Nexium Study To Suppress Nausea During Chemotherapy
NCT00206440 · Baylor Breast Care Center, Other · Terminated
Key facts
| NCT number | NCT00206440 |
|---|---|
| Title | Nexium Study To Suppress Nausea During Chemotherapy |
| Official title | Evaluation of the Efficacy of Esomeprazole in Suppressing Nausea and Vomiting in Patients Undergoing Chemotherapy for Breast Cancer |
| Acronym | NEXIUM |
| Lead sponsor | Baylor Breast Care Center, Other |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea |
| Intervention type | Drug, Other |
| Interventions | esomeprazole, Placebo |
| Enrollment | 43 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: